Search research articles
Contact Us
Filters
Showing results (1-10 of 59) with videos related to
Page
of 6
Sort By:
Investigational New Drugs
|
March 18, 2014
Contributions from emerging transcriptomics technologies and computational strategies for drug discovery
Onat Kadioglu, Thomas Efferth
Journal of Natural Products
|
February 26, 2015
Pharmacogenomic Characterization of Cytotoxic Compounds from Salvia officinalis in Cancer Cells
Onat Kadioglu, Thomas Efferth
Investigational New Drugs
|
March 15, 2016
Peptide aptamer identified by molecular docking targeting translationally controlled tumor protein in leukemia cells
Onat Kadioglu, Thomas Efferth
Cells
|
October 24, 2019
A Machine Learning-Based Prediction Platform for P-Glycoprotein Modulators and Its Validation by Molecular Docking
Onat Kadioglu, Thomas Efferth
Pharmaceuticals (Basel, Switzerland)
|
October 23, 2021
Identification of Novel Anthracycline Resistance Genes and Their Inhibitors
Onat Kadioglu, Mohamed Elbadawi, Edmond Fleischer, et al.
International Journal of Molecular Sciences
|
February 15, 2022
Kinome-Wide Profiling Identifies Human WNK3 as a Target of Cajanin Stilbene Acid from <i>Cajanus cajan</i> (L.) Millsp
Nadire Özenver, Onat Kadioglu, Yujie Fu, et al.
Computers in Biology and Medicine
|
April 12, 2021
Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning
Onat Kadioglu, Mohamed Saeed, Henry Johannes Greten, et al.
Frontiers in Pharmacology
|
February 18, 2017
Pharmacogenomic Characterization and Isobologram Analysis of the Combination of Ascorbic Acid and Curcumin-Two Main Metabolites of <i>Curcuma longa</i>-in Cancer Cells
Edna Ooko, Onat Kadioglu, Henry J Greten, et al.
The Journal of Nutritional Biochemistry
|
December 3, 2014
Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking
Mohamed Saeed, Onat Kadioglu, Hassan Khalid, et al.
Frontiers in Neuroscience
|
February 23, 2013
Synergy and Antagonism of Active Constituents of ADAPT-232 on Transcriptional Level of Metabolic Regulation of Isolated Neuroglial Cells
Alexander Panossian, Rebecca Hamm, Onat Kadioglu, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 59) with videos related to
Sort By:
Page
of 6
Investigational New Drugs
|
March 18, 2014
Contributions from emerging transcriptomics technologies and computational strategies for drug discovery
Onat Kadioglu, Thomas Efferth
Journal of Natural Products
|
February 26, 2015
Pharmacogenomic Characterization of Cytotoxic Compounds from Salvia officinalis in Cancer Cells
Onat Kadioglu, Thomas Efferth
Investigational New Drugs
|
March 15, 2016
Peptide aptamer identified by molecular docking targeting translationally controlled tumor protein in leukemia cells
Onat Kadioglu, Thomas Efferth
Cells
|
October 24, 2019
A Machine Learning-Based Prediction Platform for P-Glycoprotein Modulators and Its Validation by Molecular Docking
Onat Kadioglu, Thomas Efferth
Pharmaceuticals (Basel, Switzerland)
|
October 23, 2021
Identification of Novel Anthracycline Resistance Genes and Their Inhibitors
Onat Kadioglu, Mohamed Elbadawi, Edmond Fleischer, et al.
International Journal of Molecular Sciences
|
February 15, 2022
Kinome-Wide Profiling Identifies Human WNK3 as a Target of Cajanin Stilbene Acid from <i>Cajanus cajan</i> (L.) Millsp
Nadire Özenver, Onat Kadioglu, Yujie Fu, et al.
Computers in Biology and Medicine
|
April 12, 2021
Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning
Onat Kadioglu, Mohamed Saeed, Henry Johannes Greten, et al.
Frontiers in Pharmacology
|
February 18, 2017
Pharmacogenomic Characterization and Isobologram Analysis of the Combination of Ascorbic Acid and Curcumin-Two Main Metabolites of <i>Curcuma longa</i>-in Cancer Cells
Edna Ooko, Onat Kadioglu, Henry J Greten, et al.
The Journal of Nutritional Biochemistry
|
December 3, 2014
Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking
Mohamed Saeed, Onat Kadioglu, Hassan Khalid, et al.
Frontiers in Neuroscience
|
February 23, 2013
Synergy and Antagonism of Active Constituents of ADAPT-232 on Transcriptional Level of Metabolic Regulation of Isolated Neuroglial Cells
Alexander Panossian, Rebecca Hamm, Onat Kadioglu, et al.
Page
of 6